Course curriculum

    1. Tanios Bekaii-Saab, MD – MSI-H CRC and Emerging Immunotherapy Options

    2. Cathy Eng, MD – Moving Away from Trimodality Therapy for MSS Rectal Cancer

    3. Michael Overman, MD – Emerging Modalities in the Treatment of Oligometastatic CRC

    4. Panel Discussion

About this course

  • Free
  • 4 lessons
  • 1 hour of video content

Meeting Highlights

The Inaugural GI Cancers US Focus Meeting 2025 was kindly supported by

Our supporters part sponsored the meeting. Our supporters had no influence or input in the event.

Gold

Silver

Additional support from